Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Silvia BeaElias Campo

Abstract

To determine the clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas (DLBCL). We have examined 64 tumors at diagnosis using comparative genomic hybridization and real-time quantitative polymerase chain reaction (PCR), single-stranded conformational polymorphism, and DNA sequencing for the analysis of several potential target genes. The most recurrent alterations were gains of 18q (20%), Xq (15%), 2p, 7q, and 12p (14%), and losses of 6q and 17p (14%). Frequent high-level DNA amplifications were detected at 2p13-p16 and 18q21 loci. Real-time quantitative PCR detected REL and BCL11A gene amplifications in the nine patients with gains at 2p13-p16 and only in one additional patient with normal chromosome 2. Similarly, the BCL-2 gene was amplified in the 12 tumors with gains of 18q21 but in none of 39 patients with normal 18q profile. p53 gene inactivation was detected in nine of 58 (16%) tumors and was commonly associated with 17p losses. Tumors with 18q gains were significantly associated with a high number of chromosomal imbalances, primary nodal presentation, high serum lactate dehydrogenase levels, high International Prognostic Index, shorter cause-specific survival, an...Continue Reading

References

Apr 20, 1989·The New England Journal of Medicine·J J YunisG Frizzera
Jun 1, 1988·Blood Reviews·A M Levine
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jan 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S C TangS Poppema
Apr 8, 1993·The New England Journal of Medicine·J O Armitage
Aug 21, 1997·The New England Journal of Medicine·A IchikawaT Hotta
May 25, 1999·Genes, Chromosomes & Cancer·J C CigudosaR S Chaganti
Jun 1, 1999·Leukemia & Lymphoma·O MonniS Knuutila
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N L HarrisC D Bloomfield
Mar 10, 2001·Genes, Chromosomes & Cancer·D E HorsmanR D Gascoyne
Nov 8, 2001·Leukemia & Lymphoma·S RantanenS Knuutila
Feb 7, 2002·Blood·José I Martín-SuberoReiner Siebert
Feb 19, 2002·Cancer Genetics and Cytogenetics·Bhavana J DaveWarren G Sanger
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Aug 16, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Mattias BerglundSvetlana Lagercrantz
Nov 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas ViardotMartin Bentz
Apr 30, 2003·Nature Immunology·Pentao LiuNeal G Copeland

❮ Previous
Next ❯

Citations

Jun 10, 2010·Head and Neck Pathology·Indraneel BhattacharyyaSamer Z Al-Quran
Mar 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lisa M RimszaLouis M Staudt
Aug 13, 2011·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Salah A Al-HumoodFahd Al-Mulla
Aug 7, 2009·Ocular Immunology and Inflammation·Sarah E CouplandJustine Smith
Jun 10, 2008·Expert Opinion on Emerging Drugs·Shireen Kassam, Silvia Montoto
Dec 29, 2015·Leukemia Research·Huiquan TaoBin Yin
Nov 18, 2015·Annals of Hematology·Elena SebastiánMarcos González
Jul 7, 2009·Hematology/oncology Clinics of North America·Laurence de Leval, Robert Paul Hasserjian
Jun 27, 2006·Clinical Lymphoma & Myeloma·Latha Shivakumar, James O Armitage
Jun 12, 2009·Cancer·Cristina RobledoUNKNOWN Spanish Lymphoma/ Autologous Bone Marrow Transplant Study Group (GEL-TAMO)
Mar 8, 2006·European Journal of Haematology·Roxana CerretiniIrma Slavutsky
Jul 5, 2007·British Journal of Haematology·Amanda P LigginsAlison H Banham
Jul 19, 2013·European Journal of Haematology·Idun FiskvikHarald Holte
May 13, 2014·Cancer Science·Miyuki SuguroMasao Seto
Aug 30, 2014·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Jaclyn A BiegelBernard E Weissman
Dec 24, 2005·Pathology·Lynda J Campbell
Nov 8, 2011·The American Journal of Pathology·Chi Young OkFrancisco Vega
Jun 11, 2016·Leukemia Research·Jiawei YinBin Yin
Jun 11, 2014·Journal of Clinical Pathology·Claudia AugelloSilvano Bosari
Jan 19, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javeed IqbalWing C Chan
Feb 25, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Armando López-GuillermoEmili Montserrat

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.